Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT02498769
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 1/2
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT02498769
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02498769. Randomized; quadruple masking; primary purpose prevention. Start 2015-09 (actual); primary completion 2017-09-28 (actual). Results posted on 2018-12-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Botulinum Toxin Type A
- Intervention (Drug)
- Placebo
- Lead sponsor
- Joseph Mathew, M.D.
- Collaborator
- Foundation for Anesthesia Education and Research
- Collaborator
- American Heart Association
Record details
- Record id
cardio:ct-nct02498769- Content hash
ea6675703b60a152a499e6518fd6018f0f7d8ac34b5df4696c1f0c7d0781f14a